Security key
56600D107
MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)
CUSIP: 56600D107
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Class A Common Stock, par value $0.01 per share
- Total 13F shares
- 129,598,496
- Total 13F value
- $312,340,233
- Share change
- +1,213,901
- Put/Call ratio
- 9.1%
- SEC-reported price per share
- $2.41
- Number of holders
- 147
- Value change
- +$3,793,871
- Number of buys
- 76
- Number of sells
- 95
- Shares outstanding
- 148,167,245
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
147
Top holders
10
MRVI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
MARAVAI LIFESCIENCES HOLDINGS, INC. SEC filings
MARAVAI LIFESCIENCES HOLDINGS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 56600D107
Recent filing periods:
Ownership snapshot
Top reported holders of MRVI - MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Kevin Herde
Disclosed value leader
GTCR LLC
Comparable rows
15/15
Latest evidence
16 Jun 2025
3/4/5
13F
Lead comparable stake: 0.46%
Showing 1-6 of 15 holder rows.
Quick read
Kevin Herde leads the comparable SEC ownership view at 0.46%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Kevin Herde's linked filing trail.
Comparable ownership
Top 5
Kevin Herde
0.46%
Jessica Hopfield
0.13%
Murali K. Prahalad
0.1%
Benjamin James Daverman
0.09%
GTCR LLC
14%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Kevin Herde |
3/4/5
Chief Financial Officer
|
0.46%
|
$1,126,642
674,636 shares
|
— | 15 May 2025 |
| Jessica Hopfield |
3/4/5
Director
|
0.13%
|
$431,799
199,907 shares
|
— | 16 Jun 2025 |
| Murali K. Prahalad |
3/4/5
Director
|
0.1%
|
$333,951
154,607 shares
|
— | 16 Jun 2025 |
| Benjamin James Daverman |
3/4/5
Director
|
0.09%
|
$298,198
138,055 shares
|
— | 16 Jun 2025 |
| GTCR LLC |
13F
Company
|
14%
|
$44,531,511
20,150,005 shares
|
— | 31 Mar 2025 |
| 12 West Capital Management LP |
13F
Company
|
8.5%
|
$27,672,150
12,521,335 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
147
Shares
129,598,496
Rows available
147
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
183
Q2 2025 holders
147
Holder diff
-36
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend